Asset sale Completed
Bora Pharmaceuticals Co. acquisition of MacroGenics GMP manufacturing site and CDMO operations
US$123m consideration
Announced 11 May 2026
Advisers
MacroGenics GMP manufacturing site and CDMO operations
Target
- Financial adviser
- Legal adviser
- Target
- MacroGenics GMP manufacturing site and CDMO operations
- Acquirer
- Bora Pharmaceuticals Co.
- Seller
- MacroGenics
- Target based in
- United States
- Buyer based in
- Taiwan
- Seller based in
- United States
- Completed
- 2 Jul 2026
- Sector
- Pharmaceutical Manufacturing
- Tags
- Pharmaceutical Manufacturing, Contract Manufacturing, Pharma Services
In the league tables
- M&A financial advisers, 2026 to date Moelis & Company #15
- M&A financial advisers, completed, 2026 to date Moelis & Company #20
- M&A legal advisers, 2026 to date Covington & Burling #10 · Sidley Austin #13 · Jones Day #19
- M&A legal advisers, completed, 2026 to date Covington & Burling #8 · Sidley Austin #13 · Jones Day #15
Similar deals
- Samsung Biologics Co. acquisition of PolyPeptide Group AG Jul 2026 · US$1.5bn · Pharma Services
- CordenPharma acquisition of AmbioPharm May 2026 · Pharma Services
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- Apax Partners acquisition of Gerresheimer global Primary Packaging Plastics business Jul 2026 · US$1.7bn · Packaging
- BC Partners stake in InfoRLife SA Jul 2026 · Pharma Services
Sources
- 11 May 2026 Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing Operations sidley.com
- 12 May 2026 Press release (EX-99.1, exhibit), MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals sec.gov
- 7 Jul 2026 Press release (EX-99.1, exhibit), MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals sec.gov



